257 related articles for article (PubMed ID: 37627142)
21. Neoadjuvant Therapy of DOF Regimen Plus Bevacizumab Can Increase Surgical Resection Ratein Locally Advanced Gastric Cancer: A Randomized, Controlled Study.
Ma J; Yao S; Li XS; Kang HR; Yao FF; Du N
Medicine (Baltimore); 2015 Oct; 94(42):e1489. PubMed ID: 26496252
[TBL] [Abstract][Full Text] [Related]
22. PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.
Kang YK; Yook JH; Park YK; Lee JS; Kim YW; Kim JY; Ryu MH; Rha SY; Chung IJ; Kim IH; Oh SC; Park YS; Son T; Jung MR; Heo MH; Kim HK; Park C; Yoo CH; Choi JH; Zang DY; Jang YJ; Sul JY; Kim JG; Kim BS; Beom SH; Cho SH; Ryu SW; Kook MC; Ryoo BY; Kim HK; Yoo MW; Lee NS; Lee SH; Kim G; Lee Y; Lee JH; Noh SH
J Clin Oncol; 2021 Sep; 39(26):2903-2913. PubMed ID: 34133211
[TBL] [Abstract][Full Text] [Related]
23. Surgery for locally advanced gastric cancer in the era of neoadjuvant therapies: something new?
Rosa F; Laterza V; Schena CA; Tondolo V; Strippoli A; Covino M; Pacini G; Quero G; Fiorillo C; DE Sio D; Tortora G; Alfieri S
Minerva Surg; 2023 Oct; 78(5):481-489. PubMed ID: 37283508
[TBL] [Abstract][Full Text] [Related]
24. Role of microsatellite instability and HER2 positivity in locally advanced esophago-gastric cancer patients treated with peri-operative chemotherapy.
Gervaso L; Bottiglieri L; Meneses-Medina MI; Pellicori S; Biffi R; Fumagalli Romario U; De Pascale S; Sala I; Bagnardi V; Barberis M; Cella CA; Fazio N
Clin Transl Oncol; 2023 Nov; 25(11):3287-3295. PubMed ID: 37084152
[TBL] [Abstract][Full Text] [Related]
25. Treatment Response Predictors of Neoadjuvant Therapy for Locally Advanced Gastric Cancer: Current Status and Future Perspectives.
Sato Y; Okamoto K; Kawaguchi T; Nakamura F; Miyamoto H; Takayama T
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884916
[TBL] [Abstract][Full Text] [Related]
26. Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines.
Wang XZ; Zeng ZY; Ye X; Sun J; Zhang ZM; Kang WM
World J Gastrointest Oncol; 2020 Jan; 12(1):37-53. PubMed ID: 31966912
[TBL] [Abstract][Full Text] [Related]
27. Pathologic Complete Response After Gastric Artery Chemoembolization Combined With Tislelizumab for Neoadjuvant Therapy of Locally Advanced Gastric Cancer: A Case Report.
Lin Y; Chen Y; Lin S; Zheng J; Zhang X; Gan L
J Immunother; 2024 Apr; 47(3):101-105. PubMed ID: 38037229
[TBL] [Abstract][Full Text] [Related]
28. Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?
Bozkaya Y; Özdemir NY; Sezer S; Köstek O; Demirci NS; Yazıcı O; Erdem GU; Eren T; Zengin N
Cancer Biomark; 2018; 22(1):143-149. PubMed ID: 29562501
[TBL] [Abstract][Full Text] [Related]
29. Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.
Fujitani K; Nakamura K; Mizusawa J; Kuwata T; Shimoda T; Katayama H; Kushima R; Taniguchi H; Yoshikawa T; Boku N; Terashima M; Fukuda H; Sano T; Sasako M;
Gastric Cancer; 2021 Jan; 24(1):197-204. PubMed ID: 32572792
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant versus adjuvant radiotherapy for resectable locally advanced gastric cancer: A SEER population analysis.
Yang G; Yang Q; Cui L; Dong Q; Meng Z; Yang C; Sun J
Heliyon; 2024 Feb; 10(3):e25461. PubMed ID: 38356572
[TBL] [Abstract][Full Text] [Related]
31. Clinical Management of Gastric Cancer Treatment Regimens.
Boilève J; Touchefeu Y; Matysiak-Budnik T
Curr Top Microbiol Immunol; 2023; 444():279-304. PubMed ID: 38231223
[TBL] [Abstract][Full Text] [Related]
32. Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives.
Sato Y; Okamoto K; Kawano Y; Kasai A; Kawaguchi T; Sagawa T; Sogabe M; Miyamoto H; Takayama T
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510761
[TBL] [Abstract][Full Text] [Related]
33. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
34. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of immunotherapy plus chemotherapy as neoadjuvant treatment for patients with locally advanced gastric cancer: a retrospective cohort study.
Wang X; Huang J; Huang H; Liu Y; Ji C; Liu J
Invest New Drugs; 2023 Aug; 41(4):579-586. PubMed ID: 37368088
[TBL] [Abstract][Full Text] [Related]
36. Postoperative chemoradiotherapy in patients with locally advanced gastric cancer with poor pathologic response to neoadjuvant chemotherapy.
Gal O; Lewin R; Perl G; Ulitzky O; Brenner B; Kundel Y
J Cancer Res Ther; 2024 Jan; 20(1):281-284. PubMed ID: 38554334
[TBL] [Abstract][Full Text] [Related]
37. Survival Benefit of Perioperative Chemotherapy in Patients with Locally Advanced Gastric Cancer: a Propensity Score Matched Analysis.
Eom BW; Kim S; Kim JY; Yoon HM; Kim MJ; Nam BH; Kim YW; Park YI; Park SR; Ryu KW
J Gastric Cancer; 2018 Mar; 18(1):69-81. PubMed ID: 29629222
[TBL] [Abstract][Full Text] [Related]
38. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
[TBL] [Abstract][Full Text] [Related]
39. Surgical Efficacy and Safety of Patients with Locally Advanced Gastric Cancer following Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy.
Li CC; Yeh YS; Chen YC; Su WC; Chang TK; Tsai HL; Huang CW; Ma CJ; Yin TC; Chen PJ; Wang JY
J Oncol; 2022; 2022():3719241. PubMed ID: 35345514
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemotherapy in locally advanced gastric cancer: what to avoid. Preliminary analysis of a consecutive series of patients.
Rausei S; Lianos GD; Proserpio I; Ruspi L; Galli F; Frattini F; Mangano A; Rovera F; Boni L; Roukos DH; Pinotti G; Dionigi G
Tumori; 2015; 101(5):511-6. PubMed ID: 25908036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
